Milestone Pharmaceuticals Inc (MIST)

NASDAQ
Currency in USD
1.970
-0.110(-5.29%)
Closed
After Hours
1.990+0.025(+1.272%)

MIST Income Statement

Advanced Income Statement
Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa51
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-66.67%-80%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa--
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa51
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-66.67%-80%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa100%100%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa64.6462.1
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-59.64-61.1
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-38.47%-2.44%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-1,192.84%-6,109.8%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa1.251.41
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+470%+12.68%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--2.55
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa1.253.97
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-58.39-59.69
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa--
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-58.39-59.69
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-36.25%-2.22%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-1,167.76%-5,968.5%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-58.39-59.69
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-58.39-59.69
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-36.25%-2.22%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-1,167.76%-5,968.5%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa--
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-58.39-59.69
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-1.38-1.39
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-34.27%-1.02%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-1.38-1.39
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-34.27%-1.02%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa42.4542.96
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa42.4542.96
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa--
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa--
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-59.55-61.01
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-38.56%-2.44%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-1,191.06%-6,100.6%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa-59.64-61.1
* In Millions of USD (except for per share items)
<